Clinical Trial

Trial Protocol ID USOR 22093_XB002-101_Jewel-101

Trial Description

A DOSE-ESCALATION AND EXPANSION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XB002 AS SINGLE-AGENT AND COMBINATION THERAPY IN SUBJECTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS (XB002-101)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Yousuf A. Gaffar, M.D.

Sponsor

  • Exelixis

ClinicalTrials.gov NCT ID

  • NCT04925284